Genelux (GNLX) Current Leases (2022 - 2026)
Genelux's (GNLX) quarterly Current Leases came in at $316000.0 in Q1 2026, down 26.0% quarter-over-quarter from $427000.0 in Q4 2025.
Genelux (GNLX) Current Leases (2022 - 2026) Analysis & Trends
Genelux's Current Leases history runs 5 years deep, the most recent figure standing at $316000.0 for Q1 2026.
- On a quarterly basis, Current Leases changed N/A year-over-year to $316000.0 in Q1 2026; TTM through Mar 2026 was $316000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $427000.0, up 29.79% from the prior year.
- Current Leases declined to $316000.0 in Q1 2026 per GNLX's latest filing, from $427000.0 in the prior quarter.
- Across five years, Current Leases topped out at $653000.0 in Q4 2023 and bottomed at $266000.0 in Q4 2022.
- The 5-year median for Current Leases is $415000.0 (2024), against an average of $432363.6.
- Across the five-year window, Current Leases soared 145.49% in 2023 and sank 49.62% in 2024, its largest moves.
- Year by year, Current Leases stood at $266000.0 in 2022, then soared by 145.49% to $653000.0 in 2023, then sank by 49.62% to $329000.0 in 2024, then grew by 29.79% to $427000.0 in 2025, then retreated by 26.0% to $316000.0 in 2026.
- Per Business Quant, the three latest GNLX Current Leases figures stand at $316000.0 (Q1 2026), $427000.0 (Q4 2025), and $354000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 316,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 354,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 584,000.00 |
| Dec 31, 2023 | 653,000.00 |
| Sep 30, 2023 | 567,000.00 |
| Dec 31, 2022 | 266,000.00 |